Glen Harbor Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Glen Harbor Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$37K	Buy	+1,190	New	+$48.6K	﹤0.01%	1251

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glen Harbor Capital Management's ADPT Position: Q3 2019 in Review

Glen Harbor Capital Management opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2019: 1,190 shares worth $37K. The stake represents ﹤0.01% of the portfolio and ranks #1251 among its holdings.

117 funds tracked by Wall St. Rank hold ADPT as of Q3 2019.

Glen Harbor Capital Management held 1,190 shares of Adaptive Biotechnologies worth $37K as of Q3 2019.
Adaptive Biotechnologies was a new Glen Harbor Capital Management position in Q3 2019.
Adaptive Biotechnologies made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1251 holding.
117 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.